Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum

Journal of Dermatological Science

Volumn 75, Issue 2, 2014, Pages 109-120

  Dabisch Ruthe, Mareike ^a   Kuzaj, Patricia ^a   Götting, Christian ^b   Knabbe, Cornelius ^a   Hendig, Doris ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MVZ Labor Limbach Nürnberg   (Germany)

Author keywords

ABCC6; Bisphosphonate; Calcification; Ectonucleotide pyrophosphatase 1; Pseudoxanthoma elasticum; Pyrophosphate; Tissue nonspecific alkaline phosphate

Indexed keywords

ALKALINE PHOSPHATE; DISODIUM HYDROGEN PHOSPHATE; ECTONUCLEOTIDE PYROPHOSPHATASE 1; MESSENGER RNA; OSTEOPONTIN; PYROPHOSPHATE; PYROPHOSPHORIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ABCC6 PROTEIN, HUMAN; ALKALINE PHOSPHATASE; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; INORGANIC PYROPHOSPHATASE; MULTIDRUG RESISTANCE PROTEIN; PHOSPHODIESTERASE; SPP1 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE CALCIFICATION; CALCINOSIS; CASE CONTROL STUDY; CELL CULTURE; ELASTIC TISSUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME;

ALKALINE PHOSPHATASE; CALCINOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; DIPHOSPHATES; ELASTIC TISSUE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OSTEOPONTIN; PHOSPHORIC DIESTER HYDROLASES; PSEUDOXANTHOMA ELASTICUM; PYROPHOSPHATASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84902822578     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.04.015     Document Type: Article

References (45)

1. Bergen A.A.B., Plomp A.S., Schuurman E.J., Terry S., Breuning M., Dauwerse H., et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000, 25(2):228-231.
2. Le Saux O., Urban Z., Tschuch C., Csiszar K., Bacchelli B., Quaglino D., et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000, 25(2):223-227.
3. Ringpfeil F., Lebwohl M.G., Christiano A.M., Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci 2000, 97(11):6001-6006.
4. Hendig D., Zarbock R., Szliska C., Kleesiek K., Götting C. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 2008, 41(6):407-412.
5. Hendig D., Schulz V., Arndt M., Szliska C., Kleesiek K., Götting C. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 2006, 52(2):227-234.
6. Gheduzzi D., Boraldi F., Annovi G., DeVincenzi C.P., Schurgers L.J., Vermeer C., et al. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 2007, 87(10):998-1008.
7. Jiang Q., Dibra F., Lee M.D., Oldenburg R., Uitto J. Overexpression of fetuin-a counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc6-/-). J Invest Dermatol 2010, 130(5):1288-1296.
8. Jiang Q., Li Q., Uitto J. Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 2007, 127(6):1392-1402.
9. Boraldi F., Annovi G., Vermeer C., Schurgers L.J., Trenti T., Tiozzo R., et al. Matrix Gla Protein and Alkaline Phosphatase Are Differently Modulated in Human Dermal Fibroblasts from PXE Patients and Controls. J Invest Dermatol 2012.
10. Terkeltaub R.A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001, 281(1):C1-C11.
11. Rutsch F., Nitschke Y., Terkeltaub R. Genetics in arterial calcification pieces of a puzzle and cogs in a wheel. Circ Res 2011, 109(5):578-592.
12. Harmey D., Hessle L., Narisawa S., Johnson K.A., Terkeltaub R., Millán J.L. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004, 164(4):1199-1209.
13. Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011, 109(6):697-711.
14. Iravathy Goud Kalal D.S., Panda A., Nitschke Y., Rutsch F. Molecular diagnosis of generalized arterial calcification of infancy (GACI). J Cardiovas Dis Res 2012, 3(2):150.
15. Nitschke Y., Baujat G., Botschen U., Wittkampf T., du Moulin M., Stella J., et al. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012, 90(1):25.
16. Le Boulanger G., Labreze C., Croue A., Schurgers L., Chassaing N., Wittkampf T., et al. An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A 2009, 152(1):118-123.
17. Hendig D., Langmann T., Kocken S., Zarbock R., Szliska C., Schmitz G., et al. Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis. Lab Invest 2008, 88(12):1303-1315.
18. Hooff G.P., Volmer D.A., Wood W.G., Müller W.E., Eckert G.P. Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP). Anal Bioanal Chem 2008, 392(4):673-680.
19. Açil Y., Moller B., Niehoff P., Rachko K., Gassling V., Wiltfang J., et al. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg 2011.
20. Gregory C.A., Grady Gunn W., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329(1):77-84.
21. Prosdocimo D.A., Douglas D.C., Romani A.M., O'Neill W.C., Dubyak G.R. Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. Am J Physiol Cell Physiol 2009, 296(4):C828-C839.
22. Lau W.M., Doucet M., Stadel R., Huang D., Weber K.L., Kominsky S.L. Enpp1: a potential facilitator of breast cancer bone metastasis. PLoS One 2013, 8(7):e66752.
23. Rutsch F., Ruf N., Vaingankar S., Toliat M.R., Suk A., Hohne W., et al. Mutations in ENPP1 are associated with'idiopathic'infantile arterial calcification. Nat Genet 2003, 34(4):379-381.
24. i depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol 2005, 25(4):686-691.
25. Ho A.M., Johnson M.D., Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000, 289(5477):265-270.
26. Villa-Bellosta R., Bogaert Y.E., Levi M., Sorribas V. Characterization of phosphate transport in rat vascular smooth muscle cells implications for vascular calcification. Arterioscler Thromb Vasc Biol 2007, 27(5):1030-1036.
27. El Husseini D., Boulanger M.-C., Fournier D., Mahmut A., Bossé Y., Pibarot P., et al. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS One 2013, 8(1):e53393.
28. Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000, 87(7):e10-e17.
29. Yoshiko Y., Candeliere G.A., Maeda N., Aubin J.E. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 2007, 27(12):4465-4474.
30. Nitschke Y., Rutsch F. Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc Med 2012, 22(6):145-149.
31. Jansen R.S., Küçükosmanouglu A., de Haas M., Sapthu S., Otero J.A., Hegman I.E., et al. ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Nat Acad Sci 2013, 110(50):20206-20211.
32. Ivandic B., Utz H., Kaczmarek P., Aherrahrou Z., Axtner S., Klepsch C., et al. New Dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Physiol Genomics 2001, 6(3):137.
33. Contri M.B., Boraldi F., Taparelli F., De Paepe A., Ronchetti I.P. Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis. Am J Pathol 1996, 148(2):569.
34. Xu H.G., Li Z.R., Wang H., Liu P., Xiang S.N., Wang C.D., et al. Expression of ectonucleotide pyrophosphatase-1 in end-plate chondrocytes with transforming growth factor beta 1 siRNA interference by cyclic mechanical tension. Chin Med J 2013, 126(20):3886-3890.
35. Chen C.-L., Liu I.-H., Fliesler S.J., Han X., Huang S.S., Huang J.S. Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci 2007, 120(20):3509-3521.
36. Russell R.G.G., Xia Z., Dunford J.E., Oppermann U., Kwaasi A., Hulley P.A., et al. Bisphosphonates. Ann N Y Acad Sci 2007, 1117(1):209-257.
37. Persy V., De Broe M., Ketteler M. Bisphosphonates prevent experimental vascular calcification: treat the bone to cure the vessels?. Kidney Int 2006, 70(9):1537-1538.
38. Rutsch F., Boyer P., Nitschke Y., Ruf N., Lorenz-Depierieux B., Wittkampf T., et al. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet 2008, 1(2):133-140.
39. Chong C.R., Hutchins G.M. Idiopathic infantile arterial calcification: the spectrum of clinical presentations. Pediatr Dev Pathol 2007, 11(5):405-415.
40. Lomashvili K.A., Monier-Faugere M.-C., Wang X., Malluche H.H., O'Neill W.C. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009, 75(6):617-625.
41. Vaisman D.N., McCarthy A.D., Cortizo A.M. Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates. Biol Trace Elem Res 2005, 104(2):131-140.
42. Saito E., Wachi H., Sato F., Sugitani H., Seyama Y. Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells. J Atheroscler Thromb 2007, 14(6):317-324.
43. Villiotte P., Riefsnyder P., Bloomstone J., Howland J. Uptake of inorganic pyrophosphate by Bacillus megaterium. FEMS Microbiol Lett 1991, 78(2):293-296.
44. Mansurova S.E. Inorganic pyrophosphate in mitochondrial metabolism. Biochim Biophys 1989, 977(3):237-247.
45. Lunn J., Douce R. Transport of inorganic pyrophosphate across the spinach chloroplast envelope. Biochem J 1993, 290:375-379.